TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
LUNG

Pulmonx Corp

Healthcare · Medical Devices · —

2.00$ -2.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow LUNG
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-403.9% -13,143.1% -23,106.1% -92.0% -63.7% -93.6% -85.6% -84.1% -54.8% -37.6% -35.9%
1.1% 56.2% 377.1% 1.3% 1.1% 1.5% 6.5% 7.5% 2.3% 1.8% 1.3%
1.8% 1.1% 9.8% 21.7% 30.6% 32.2% 27.4% 23.5%
277.0% 2,548.9% 3,294.7% 6.5% 6.0% 5.8% 24.2% 31.7%
-7.6% -7.4% -14.6% -16.2% -13.2% -3.7% -2.0% -2.1%
19.0% 845.7% 309.0% 1.6% 2.2% 2.8% 7.6% 2.5% 1.2% 1.7% 0.5%
-19.0% -845.7% -304.6% 1.0% -43.7% 38.8% -95.5% -7.9% -2.9% 20.9% 33.7%
141.7% 0.1% 31.2%
316.6% 5,519.1% 17,031.0% 0.0% -0.1% -0.1% -0.1% 1.7% 1.5%
81.3% 10,770.5% 1,272.7% 60.0% 18.4% 100.8% -0.1% -0.3% 29.0% -0.1% -0.1%
397.9% 16,289.5% 18,303.8% 60.6% 140.0% 717.4% 9.3% 4.6% 31.2% 1.6% 1.0%
-25.0% 2,300.7% -4,802.3% -29.6% 32.7% 663.0% -171.6% -87.1% -26.5% -15.1% -1.3%
-93.5% -65.9% -96.4% -93.2% -86.6% -55.9% -39.4% -36.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?